Psychedelics

Article

Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Article

Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Article

Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript

In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.

Article

Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript

In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.

Article

The Psychedelic Syndicate: Part 4

Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal.

Article

The Psychedelic Syndicate: Part 3

Part 3 of The Psychedelic Syndicate exposes how Silicon Valley’s “move fast and break things” mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised…

Article

The Psychedelic Syndicate: Part 2

Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC’s influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval.

Article

The Psychedelic Syndicate: Part 1

Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and…

Article

Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia

Rather than unpacking the actual causes of Lykos Therapeutics’ disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.

Article

Correcting the Record: What The New York Times Got Wrong

In response to The New York Times February 4 article, “How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy,” Psymposia requested corrections to numerous errors and false accusations.

Article

Psymposia’s Response to Heroic Hearts’ Pharma-Backed Press Conference

Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns.

Article

Every Disclosed Conflict of Interest at Psychedelic Science 2023

All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list.